Jiangsu Cowin Biotech Co (SHSE:688426) ROC % : -18.07% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jiangsu Cowin Biotech Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Jiangsu Cowin Biotech Co's annualized return on capital (ROC %) for the quarter that ended in Sep. 2024 was -18.07%.

As of today (2025-03-27), Jiangsu Cowin Biotech Co's WACC % is 10.21%. Jiangsu Cowin Biotech Co's ROC % is -16.93% (calculated using TTM income statement data). Jiangsu Cowin Biotech Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Jiangsu Cowin Biotech Co ROC % Historical Data

The historical data trend for Jiangsu Cowin Biotech Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Cowin Biotech Co ROC % Chart

Jiangsu Cowin Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROC %

Get a 7-Day Free Trial

18.64

124.30

69.51

49.63

-14.53

Jiangsu Cowin Biotech Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROC %	Get a 7-Day Free Trial													-23.48	-24.49	-15.45	-10.14	-18.07

Jiangsu Cowin Biotech Co ROC % Calculation

Jiangsu Cowin Biotech Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

	ROC % (A: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2022 )	+	Invested Capital (A: Dec. 2023 ))	/ count )
=	-105.251 * ( 1 - 9.94% )	/	( (442.929	+	861.991)	/ 2 )
=	-94.7890506	/	652.46
=	-14.53 %

where

	Invested Capital		(A: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1955.26	-	78.203	-	( 1434.128	-	max(0, 93.148	-	1626.664	+	1434.128	))
=	442.929

	Invested Capital		(A: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1822.219	-	66.605	-	( 893.623	-	max(0, 84.862	-	1084.68	+	893.623	))
=	861.991

Jiangsu Cowin Biotech Co's annualized Return on Capital (ROC %) for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	-179.944 * ( 1 - 2.71% )	/	( (964.609	+	972.878)	/ 2 )
=	-175.0675176	/	968.7435
=	-18.07 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1735.144	-	43.903	-	( 726.632	-	max(0, 64.46	-	992.995	+	726.632	))
=	964.609

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1670.367	-	44.153	-	( 653.336	-	max(0, 62.782	-	895.443	+	653.336	))
=	972.878

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

Jiangsu Cowin Biotech Co (SHSE:688426) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Jiangsu Cowin Biotech Co's WACC % is 10.21%. Jiangsu Cowin Biotech Co's ROC % is -16.93% (calculated using TTM income statement data). Jiangsu Cowin Biotech Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Jiangsu Cowin Biotech Co ROC % Related Terms

Thank you for viewing the detailed overview of Jiangsu Cowin Biotech Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Cowin Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jiangsu Cowin Biotech Co Ltd (SHSE:688426) » Definitions » ROC %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Yaocheng Avenue, 4th Floor, TQB Building, Jiangsu Province, Taizhou, CHN, 225300

Website

https://www.cwbio.com

Jiangsu Cowin Biotech Co Ltd is a national high-tech enterprise with independent intellectual property rights based in the field of life sciences. It provides innovative biological products and services to in vitro diagnostic users. The product line mainly includes molecular diagnostic raw materials enzymes, nucleic acid collection and protection agents, nucleic acid extraction kits, molecular diagnostic detection reagents and others.

Executives

Yin Jian Feng	Director
Zhuang Zhi Hua	Directors, senior managers

Jiangsu Cowin Biotech Co Headlines

No Headlines